Stenocare A/S (CPH:STENO)
Denmark · Delayed Price · Currency is DKK 0.9360
+0.0060 (0.65%)
Aug 17, 2026, 4:54 PM CET
Stenocare Revenue
Stenocare had revenue of 3.00M DKK in the quarter ending March 31, 2026, with 284.16% growth. This brings the company's revenue in the last twelve months to 9.24M, up 397.09% year-over-year. In the year 2025, Stenocare had annual revenue of 7.02M with 214.56% growth.
Revenue (ttm)
9.24M
Revenue Growth
+397.09%
P/S Ratio
4.37
Revenue / Employee
2.31M
Employees
4
Market Cap
40.43M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 7.02M | 4.79M | 214.56% |
| Dec 31, 2024 | 2.23M | -1.53M | -40.61% |
| Dec 31, 2023 | 3.76M | -731.58K | -16.30% |
| Dec 31, 2022 | 4.49M | 2.60M | 137.54% |
| Dec 31, 2021 | 1.89M | 1.69M | 852.38% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Novo Nordisk | 329.43B |
| Coloplast | 28.05B |
| Genmab | 27.03B |
| Demant | 24.63B |
| Gubra | 2.64B |
| Scandinavian Medical Solutions | 214.99M |
| BioPorto | 40.29M |
| ViroGates | 9.01M |
Stenocare News
- 3 months ago - Stenocare Quarterly report: Q1 2026 - Filings
- 6 months ago - Stenocare Quarterly report: Q4 2025 - Filings
- 10 months ago - Stenocare Quarterly report: Q3 2025 - Filings
- 1 year ago - Stenocare Quarterly report: Q2 2025 - Filings